A proprietary nanotechnology platform for intracellular delivery of biologics, enabling targeting of previously undruggable intracellular cancer targets.

Development of novel cancer treatments using MPN Technology® to deliver biologics and small molecules intracellularly to address unmet medical needs in oncology.